about
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transitionEarly recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification.Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disordersThe Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms.The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study.Early detection and secondary prevention of psychosis: facts and visions.Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis.Reduced hippocampal volume correlates with executive dysfunctioning in major depression.Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disordersDisease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging studyMenopause and schizophrenia.Executive function improvement upon remission of recurrent unipolar depression.Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states.Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis.Clinical correlates of later violence and criminal offences in schizophrenia.Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.Association between psychopathology and problems of psychosocial functioning in the long-term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders.Cincinnati criteria for mixed mania and suicidality in patients with acute mania.Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study.Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis.Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis.Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment.The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.[Recovery is an illusion - pro & contra].Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response.Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects.Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes.Hippocampal changes in patients with a first episode of major depression.Enlargement of the amygdala in patients with a first episode of major depression.Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients.Depression-related variation in brain morphology over 3 years: effects of stress?[Neuropsychological Functioning as a Predictor of Treatment Response to Psychoeducational, Cognitive Behavioral Therapy in People at Clinical High Risk of First Episode Psychosis].Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course.Coping as a predictor of treatment outcome in people at clinical high risk of psychosis.Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission.Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.Impaired action control in schizophrenia: the role of volitional saccade initiation.
P50
Q30432820-04D46C0F-0685-4D37-A91A-3B4EDAEA5490Q30447856-0A366134-6806-40FE-8CE5-4449C2D8B59AQ34048584-EE75E99C-5415-415C-B8BC-23E43E15D1C9Q34135398-F5620D9D-35B0-4504-8BD9-FBFEDFF4651FQ34309220-60576BA2-15F8-4762-88AC-527864A117C0Q34547974-CA304B7F-FACA-48F8-8053-CA4A1A325F3CQ34623245-A5A6442B-C1F4-4D04-BBB8-68916D70781EQ35012657-3EFAB8A1-1F8E-41DC-A323-4F4CCF602FCFQ35641068-9979B69F-8EAA-4FDD-8D38-10B1C50D2778Q36386359-B0A43153-3C9F-4808-A0D2-BD117DB0A404Q36857790-ED274A39-33DF-4455-8559-A9D414B59319Q37981665-B01E77E7-F7BF-4FDB-BF3C-3238686D27ADQ38416343-EE08D37C-F419-42F0-93CC-458D09E01FBAQ38470660-7C675F1F-AD31-48D2-B646-2DE116DE7293Q40135642-F743B59F-211E-422F-B6E0-028147011102Q40212051-EF63879A-F751-46DC-9AA3-3877728A6F5AQ43491943-CC7164F6-CDB9-42EB-8E53-54D735F76D16Q43602230-4BFC557E-6228-4BF6-B15F-E5E5FFE57967Q44690750-A7D67A2D-FB2D-46F1-B151-FC7DC1311AB6Q44752400-5B00D253-918B-448C-BB01-46B91CB0B736Q44944800-F7C0FFF0-7919-4ECB-92BB-A0E769ACB75AQ44978654-C7A68A47-A343-4B47-B12D-55AF2CF08803Q45962624-1FB073A7-01B4-457C-9AEF-BFCCEBDD07EAQ46628180-A19757B6-DE6E-4FB4-B87B-153E4E67D7FBQ46701681-28CF971D-7271-4CFF-A9B5-C1EE40F5B337Q46773847-37B02188-D9F3-4537-8059-D41F08CAF0EDQ48219987-4AE5BD1E-B46A-42CE-8356-3030E06B613CQ48275728-6C814691-A904-4B66-A2C6-044683F26083Q48388265-2E1CE63E-BA3F-495F-BE88-B2D38A14500DQ48470818-5322EA42-BBA1-4BB7-AFD5-B15C5D80521CQ48564609-D1548224-D6D7-418D-8A14-B9E20037F0ADQ48619140-E35BF5A0-2724-4C7F-A44C-5A119185229AQ48660575-1AF1FD4E-BA78-4659-9C6D-5C2026CF556EQ48891594-1BB18965-A871-4662-A276-B7F7A5BE9885Q50713241-03954BC7-2610-4169-B47A-055577E7AF3FQ50795907-4FEE1011-49B1-494F-9436-E6FEDBA235BFQ51749483-4FA5ABE7-0969-494E-9AD3-FE9967C6DFD8Q51860973-93BA3B69-F691-4EF3-B43D-B729892FB4E2Q51893763-143D1D99-A1CE-463C-972E-26E1B1981923Q51924373-0EDC304E-E974-4BF7-B5A9-AF2951C865B2
P50
description
researcher ORCID ID = 0000-0003-2886-8832
@en
wetenschapper
@nl
name
Ronald Bottlender
@ast
Ronald Bottlender
@en
Ronald Bottlender
@es
Ronald Bottlender
@nl
type
label
Ronald Bottlender
@ast
Ronald Bottlender
@en
Ronald Bottlender
@es
Ronald Bottlender
@nl
prefLabel
Ronald Bottlender
@ast
Ronald Bottlender
@en
Ronald Bottlender
@es
Ronald Bottlender
@nl
P21
P31
P496
0000-0003-2886-8832